News & Updates
Filter by Specialty:
Leuprolide acetate maintains QOL scores in prostate cancer patients despite worsening condition
05 Oct 2021
Treatment with leuprolide acetate every 6 months does not elicit significant changes in health-related quality of life (HRQOL) among prostate cancer (PC) patients despite substantial deterioration of body and role functions, a recent study has found.
Leuprolide acetate maintains QOL scores in prostate cancer patients despite worsening condition
05 Oct 2021
YouTube a good way to educate patients about male infertility
03 Oct 2021
YouTube has increasingly become an avenue for delivering information about male infertility, though crucial knowledge gaps still exist, a recent study has found.
YouTube a good way to educate patients about male infertility
03 Oct 2021
Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction
29 Sep 2021
The combination of low-intensity shockwave therapy (Li-ESWT) with phosphodiesterase 5 inhibitor (PDE-5i) medication safely improves erectile function in vasculogenic erectile dysfunction (ED) patients who had failed first-line oral therapy, a recent study has found.
